Krishgen is an Indian biotech company established in 2003 that focuses on developing tools for the life sciences and agriculture industries. It has experienced strong growth, with revenues reaching $5 million in 2011. Krishgen provides products and services related to medical diagnostics, drug discovery research, biopharmaceuticals, and plant/food sciences. It aims to enable breakthroughs in biological research and disease treatment.
Business Excellence: Making Change Management "Value-Add"wtgevents
John Sauers from Abbott presented Business Excellence: Making Change Management "Value-Add" at the Global Pharma Manufacturing Summit 2012. More details are at www.gpmsummit.com or here is the direct link http://pgmna.wtginternational.com/od_preview.asp
Business Excellence: Making Change Management "Value-Add"wtgevents
John Sauers from Abbott presented Business Excellence: Making Change Management "Value-Add" at the Global Pharma Manufacturing Summit 2012. More details are at www.gpmsummit.com or here is the direct link http://pgmna.wtginternational.com/od_preview.asp
Best innovative pharmaceuticals firm, 2020..SophiaSmeeth
India plays a pivotal role in the global pharmaceuticals Industry by being one of the largest providers of generic drugs globally. Innovation and low costs of manufacturing are some of the clear advantages that India offers in the global space. The Pharma industry has grown exponentially over the last few years. Here we are going to feature the "Best Innovative Pharmaceuticals Firm_ 2020" that playing the best roll in Pharmaceuticals industry.
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...Merry D'souza
The 10 most innovative pharma and biotech solution providers, 2020 september 2020; Insights Success has published The 10 most innovative pharma and biotech solution providers.
OJAS offers a comprehensive suite of medical writing services to support marketing strategies. Driven with spirit to grow and with extensive experience in medical communication solutions, we provide innovative and customized platform to the clients, helping them to engage their customers beyond regular marketing promotions. Our pursuit is on a daily basis for innovation in solution to your medical communications strategies.
KRIBIOLISA Drug Monitoring ELISA Trastuzumabkrishgen
Kribiolisa ELISA kits for drug monitoring of therapeutic drugs like Adalimumab, Trastuzumab, Atezolizumab, Eculizumab, Ranibizumab. Sensitive assays for drug monitoring and immunogenicity. CE marked.
KRIBIOLISA Drug Monitoring ELISA Ranibizumabkrishgen
Kribiolisa ELISA kits for drug monitoring of therapeutic drugs like Adalimumab, Trastuzumab, Atezolizumab, Eculizumab, Ranibizumab. Sensitive assays for drug monitoring and immunogenicity. CE marked.
Best innovative pharmaceuticals firm, 2020..SophiaSmeeth
India plays a pivotal role in the global pharmaceuticals Industry by being one of the largest providers of generic drugs globally. Innovation and low costs of manufacturing are some of the clear advantages that India offers in the global space. The Pharma industry has grown exponentially over the last few years. Here we are going to feature the "Best Innovative Pharmaceuticals Firm_ 2020" that playing the best roll in Pharmaceuticals industry.
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...Merry D'souza
The 10 most innovative pharma and biotech solution providers, 2020 september 2020; Insights Success has published The 10 most innovative pharma and biotech solution providers.
OJAS offers a comprehensive suite of medical writing services to support marketing strategies. Driven with spirit to grow and with extensive experience in medical communication solutions, we provide innovative and customized platform to the clients, helping them to engage their customers beyond regular marketing promotions. Our pursuit is on a daily basis for innovation in solution to your medical communications strategies.
KRIBIOLISA Drug Monitoring ELISA Trastuzumabkrishgen
Kribiolisa ELISA kits for drug monitoring of therapeutic drugs like Adalimumab, Trastuzumab, Atezolizumab, Eculizumab, Ranibizumab. Sensitive assays for drug monitoring and immunogenicity. CE marked.
KRIBIOLISA Drug Monitoring ELISA Ranibizumabkrishgen
Kribiolisa ELISA kits for drug monitoring of therapeutic drugs like Adalimumab, Trastuzumab, Atezolizumab, Eculizumab, Ranibizumab. Sensitive assays for drug monitoring and immunogenicity. CE marked.
KRIBIOLISA Drug Monitoring ELISA Eculizumabkrishgen
Kribiolisa ELISA kits for drug monitoring of therapeutic drugs like Adalimumab, Trastuzumab, Atezolizumab, Eculizumab, Ranibizumab. Sensitive assays for drug monitoring and immunogenicity. CE marked.
KRIBIOLISA Drug Monitoring ELISA Atezolizumabkrishgen
Kribiolisa ELISA kits for drug monitoring of therapeutic drugs like Adalimumab, Trastuzumab, Atezolizumab, Eculizumab, Ranibizumab. Sensitive assays for drug monitoring and immunogenicity. CE marked.
Kribiolisa ELISA kits for drug monitoring of therapeutic drugs like Adalimumab, Trastuzumab, Atezolizumab, Eculizumab, Ranibizumab. Sensitive assays for drug monitoring and immunogenicity. CE marked.
Validation of factor xa assay for tinzaparin sodium tinzaparin injectionkrishgen
chromogenic assay intended for the quantitative determination in purified solutions by measurement of factor IIa or Xa inhibition activity. The kit can be used for 100 test reactions as per microtiter plate protocol.
Validation of factor i ia assay for tinzaparin sodium-tinzaparin injectionkrishgen
chromogenic assay intended for the quantitative determination in purified solutions by measurement of factor IIa or Xa inhibition activity. The kit can be used for 100 test reactions as per microtiter plate protocol.
Validation of factor xa assay for nadroparin calcium nadroparin injectionkrishgen
chromogenic assay intended for the quantitative determination in purified solutions by measurement of factor IIa or Xa inhibition activity. The kit can be used for 100 test reactions as per microtiter plate protocol.
Validation of factor xa assay for heparin sodium heparin injectionkrishgen
chromogenic assay intended for the quantitative determination in purified solutions by measurement of factor IIa or Xa inhibition activity. The kit can be used for 100 test reactions as per microtiter plate protocol.
Validation of factor xa assay for enoxaparin sodium enoxaparin injectionkrishgen
chromogenic assay intended for the quantitative determination in purified solutions by measurement of factor IIa or Xa inhibition activity. The kit can be used for 100 test reactions as per microtiter plate protocol.
Validation of factor xa assay for dalteparin sodium dalteparin injectionkrishgen
chromogenic assay intended for the quantitative determination in purified solutions by measurement of factor IIa or Xa inhibition activity. The kit can be used for 100 test reactions as per microtiter plate protocol.
Validation of Factor IIa for heparin sodium or heparin injectionkrishgen
A chromogenic assay intended for the quantitative determination in purified solutions by measurement of factor IIa or Xa inhibition activity. The kit can be used for 100 test reactions as per microtiter plate protocol.
Validation of Factor IIa assay for nadroparin calcium or nadroparin injectionkrishgen
A chromogenic assay intended for the quantitative determination in purified solutions by measurement of factor IIa or Xa inhibition activity. The kit can be used for 100 test reactions as per microtiter plate protocol.
Validation of Factor IIa assay for enoxaparin sodium or enoxaparin injectionkrishgen
A chromogenic assay intended for the quantitative determination in purified solutions by measurement of factor IIa or Xa inhibition activity. The kit can be used for 100 test reactions as per microtiter plate protocol.
Validation of Factor II and Xa Chromogenic Assays for Dalteparin, Enoxaparin,...krishgen
A chromogenic assay intended for the quantitative determination in purified solutions by measurement of factor IIa or Xa inhibition activity. The kit can be used for 100 test reactions as per microtiter plate protocol.
Validation of anti niv igm capture elisa version#1krishgen
NiV is a negative-sense, non-segmented RNA virus that was first isolated from cerebrospinal fluid of human patients and classified in the family Paramyxoviridae under the new genus
Henipavirus. Its genome encodes six structural proteins: the nucleocapsid (N) protein,
phosphoprotein (P), matrix (M) protein, fusion (F) protein, glycoprotein (G), and large (L)
protein.
Nipah virus glycoprotein G has a globular head domain formed of a six-bladed beta sheet propeller, connected via a flexible stalk domain to a transmembrane anchor. The G binds to the cellular receptors ephrin B2 are ephrin B3, mediating viral attachment. Following attachment Nipah Virus glycoprotein G undergoes a conformational change that leads to triggering of glycoprotein F which leads to membrane fusion (Biering et al, 2012).
The Nipah virus glycoprotein G is a recombinant protein expressed in mammalian HEK293 cells. It is presented as a fusion protein with a mouse Fc tag linked to the C-terminus of glycoprotein G, amino acids 71-602.
We established preliminary specifications defining acceptable ranges for the parameters indicated herein below for our Anti Nipah Virus IgM Capture ELISA kit. These parameters were tracked day-to-day, run-to-run, and operator-to-operator, over a schedule defined inhouse.
Recommended assay characteristics included absorbance of a zero concentration standard; factors which describe the calibration for each standard and statistical description of the calibration curve such as coefficient of correlation, slope and/or intercept; and recovery of results on control samples. It is important to be able to relate the specifications for a parameter to expected reliability of the result. Our in-house standard defined was r=0.990.
Validation of bevacizumab elisa ich q2 ver3,0 dt14.03krishgen
This document presents a discussion of the characteristics of our KRIBIOLISA™
BEVACIZUMAB ELISA kit considered by us during the validation of this kit in accordance
with ICH Q2 (R1) guidelines. The document is prepared based on tests run in our laboratory
and does not necessarily seek to cover the testing that may be required at user’s end for
registration in, or regulatory submissions. The objective of this validation is to demonstrate
that it is suitable for its intended purpose – detection of Bevacizumab (Avastin)
White Paper : Need for Standardization of Tests for Plant Viruseskrishgen
Plant virus testing in India requires standardization. There is a need for Department of Biotechnology, under the Ministry of Agriculture to work towards encouraging Indian manufacturers to develop and offer test kits at low costs suited to Indian farmers.
KRISHGEN is leading manufacturer of ELISA kits for measuring markers in rat serum or plasma. Citations are available for majority of the products and can be viewed on the website.
KRISHGEN is a leading manufacturer of fluroescent based assay kits which can be used on plate readers. With numerous citations for their products, the company is a leading assay and kits manufacturer.